BR112018001978A2 - composição farmacêutica compreendendo fibras obtidas de forma eletro-hidrodinâ¬mica, composição com tempo de permanência melhorado sobre o local de aplicação - Google Patents

composição farmacêutica compreendendo fibras obtidas de forma eletro-hidrodinâ¬mica, composição com tempo de permanência melhorado sobre o local de aplicação

Info

Publication number
BR112018001978A2
BR112018001978A2 BR112018001978A BR112018001978A BR112018001978A2 BR 112018001978 A2 BR112018001978 A2 BR 112018001978A2 BR 112018001978 A BR112018001978 A BR 112018001978A BR 112018001978 A BR112018001978 A BR 112018001978A BR 112018001978 A2 BR112018001978 A2 BR 112018001978A2
Authority
BR
Brazil
Prior art keywords
composition
residence time
time over
application site
pharmaceutical composition
Prior art date
Application number
BR112018001978A
Other languages
English (en)
Inventor
Hansen Jens
Eduardo Santocildes Romero Martin
Original Assignee
Dermtreat Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermtreat Aps filed Critical Dermtreat Aps
Publication of BR112018001978A2 publication Critical patent/BR112018001978A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nonwoven Fabrics (AREA)
  • Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)

Abstract

a presente invenção se refere a fibras fabricadas por eletro-fiação contendo: i) um primeiro e um segundo polímeros hidrofílicos formadores de fibra que são solúveis em um solvente hidrofílico; ii) uma substância bioadesiva que é pouco solúvel no referido solvente hidrofílico; iv) um fármaco, em que o primeiro polímero hidrofílico tem uma solubilidade em água a 37°c que é pelo menos algumas vezes maior do que a solubilidade em água a 37°c do segundo polímero hidrofílico formador de fibras, e em que a substância bioadesiva está presente em forma sólida.
BR112018001978A 2015-11-19 2016-11-18 composição farmacêutica compreendendo fibras obtidas de forma eletro-hidrodinâ¬mica, composição com tempo de permanência melhorado sobre o local de aplicação BR112018001978A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201570745 2015-11-19
PCT/EP2016/078151 WO2017085264A1 (en) 2015-11-19 2016-11-18 A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site

Publications (1)

Publication Number Publication Date
BR112018001978A2 true BR112018001978A2 (pt) 2018-09-18

Family

ID=58718438

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018001978A BR112018001978A2 (pt) 2015-11-19 2016-11-18 composição farmacêutica compreendendo fibras obtidas de forma eletro-hidrodinâ¬mica, composição com tempo de permanência melhorado sobre o local de aplicação

Country Status (18)

Country Link
US (4) US20180221295A1 (pt)
EP (1) EP3334412B1 (pt)
JP (2) JP6606279B2 (pt)
KR (3) KR102435996B1 (pt)
CN (1) CN108135833B (pt)
AU (2) AU2016358266B2 (pt)
BR (1) BR112018001978A2 (pt)
CA (1) CA2993377C (pt)
DK (1) DK3334412T3 (pt)
ES (1) ES2900741T3 (pt)
HK (1) HK1256209A1 (pt)
IL (1) IL258093B (pt)
MX (1) MX2018005206A (pt)
MY (1) MY167777A (pt)
NZ (1) NZ740615A (pt)
RU (2) RU2701513C2 (pt)
SG (1) SG10201913222XA (pt)
WO (1) WO2017085264A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019008258A (es) 2017-01-23 2020-01-27 Afyx Therapeutics As Metodo para la fabricacion de un producto de dos capas basado en fibras electrohiladas.
BR112019014732A2 (pt) 2017-01-23 2020-03-10 Afyx Therapeutics A/S Método para a preparação de fibras eletrofiadas com um alto teor de uma substância bioadesiva
WO2021050532A1 (en) * 2019-09-09 2021-03-18 Afyx Therapeutics A/S Compositions for treating fungal infections
US20240074970A1 (en) 2019-10-08 2024-03-07 Afyx Therapeutics A/S Compositions for the delivery of proteins
EP4108231A1 (en) * 2021-06-25 2022-12-28 Johann-Wolfgang-Goethe-Universität Frankfurt am Main In-situ dissolving electrospun polymer fibers for ocular drug delivery
PL4124336T3 (pl) * 2021-07-30 2024-02-26 Cannamedical Pharma Gmbh Plaster przezśluzówkowy obejmujący kannabinoid i/lub opioid
WO2023094457A1 (en) 2021-11-23 2023-06-01 Afyx Therapeutics A/S Mucosal patches and methods of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61280423A (ja) 1985-06-05 1986-12-11 Kiyuukiyuu Yakuhin Kogyo Kk 口腔内粘膜貼付剤
US6753454B1 (en) * 1999-10-08 2004-06-22 The University Of Akron Electrospun fibers and an apparatus therefor
CN1223340C (zh) * 2000-01-28 2005-10-19 史密丝克莱恩比彻姆公司 电纺丝的药物组合物
US7309498B2 (en) * 2001-10-10 2007-12-18 Belenkaya Bronislava G Biodegradable absorbents and methods of preparation
US20030017208A1 (en) * 2002-07-19 2003-01-23 Francis Ignatious Electrospun pharmaceutical compositions
TW200410714A (en) * 2002-08-07 2004-07-01 Smithkline Beecham Corp Electrospun amorphous pharmaceutical compositions
AU2003265446A1 (en) * 2002-08-13 2004-02-25 Medtronic, Inc. Active agent delivery system including a hydrophilic polymer, medical device, and method
WO2009120365A2 (en) * 2008-03-27 2009-10-01 Agigma, Inc. Methods and compositions for the delivery of agents
WO2013165604A1 (en) * 2012-05-02 2013-11-07 Massachusetts Institute Of Technology Electroprocessing of active pharmaceutical ingredients
CN102670483B (zh) * 2012-05-09 2014-04-02 上海交通大学 一种用于高血脂症治疗的静电纺丝纤维膜制剂及其制备方法
WO2014066297A1 (en) * 2012-10-22 2014-05-01 North Carolina State University Nonwoven fiber materials
EP2810645B1 (en) * 2013-06-06 2017-05-24 A. Sezai Sarac New Drug Delivery System
BR112016028961B1 (pt) * 2014-06-10 2023-04-11 Afyx Therapeutics A/S Composição compreendendo fibras eletrotorcidas, seu método de preparação e kit

Also Published As

Publication number Publication date
AU2016358266B2 (en) 2018-06-21
CN108135833A (zh) 2018-06-08
DK3334412T3 (da) 2022-01-17
EP3334412B1 (en) 2021-10-20
JP6606279B2 (ja) 2019-11-13
KR20190067280A (ko) 2019-06-14
CA2993377C (en) 2019-11-12
IL258093B (en) 2022-03-01
US20180221295A1 (en) 2018-08-09
KR20180040704A (ko) 2018-04-20
JP2018528256A (ja) 2018-09-27
JP6929916B2 (ja) 2021-09-01
KR102001163B1 (ko) 2019-07-18
JP2020022787A (ja) 2020-02-13
RU2018109496A3 (pt) 2019-09-19
HK1256209A1 (zh) 2019-09-13
US20240139117A1 (en) 2024-05-02
CN108135833B (zh) 2022-11-29
AU2018220020A1 (en) 2018-09-06
MY167777A (en) 2018-09-25
NZ740615A (en) 2019-06-28
ES2900741T3 (es) 2022-03-18
RU2701513C2 (ru) 2019-09-27
MX2018005206A (es) 2018-08-01
EP3334412A1 (en) 2018-06-20
KR20190020173A (ko) 2019-02-27
WO2017085264A1 (en) 2017-05-26
AU2016358266A1 (en) 2018-04-05
US20230285313A1 (en) 2023-09-14
IL258093A (en) 2018-05-31
CA2993377A1 (en) 2017-05-26
AU2018220020B2 (en) 2020-05-21
US20190254985A1 (en) 2019-08-22
SG10201913222XA (en) 2020-03-30
KR102435996B1 (ko) 2022-08-25
RU2019129082A (ru) 2020-04-28
RU2018109496A (ru) 2019-09-19
AU2018220020C1 (en) 2020-09-17

Similar Documents

Publication Publication Date Title
BR112018001978A2 (pt) composição farmacêutica compreendendo fibras obtidas de forma eletro-hidrodinâ¬mica, composição com tempo de permanência melhorado sobre o local de aplicação
MX2021001118A (es) Composiciones que comprenden fibras obtenidas electrohidrodinamicamente para la administracion de dosificaciones especificas de una sustancia activa a piel o mucosa.
BR112018015273A2 (pt) derivados de benzimidazol como moduladores de ror-gama
PE20160665A1 (es) Derivados 11-hidroxilo de acidos biliares y conjugados de aminoacidos de los mismos como moduladores del receptor de farnesoid x
DOP2014000115A (es) Uso de 4-fenil-piridinas sustituidas para la fabricación de medicamentos útiles en el tratamiento de enfermedades relacionadas con el receptor de nk1
BR112015018838A2 (pt) estabilidade melhorada de novas composições líquidas
CL2013000713A1 (es) Compuestos pirazin-2-cabonil-imino-1,3,8-triaza-espiro-[4.5]-decan-sustituidos, bloqueadores del canal de sodio epitelial (enac); composicion farmaceutica que los incluye; metodo de prevencion o tratamiento; y su uso para tratar una enfermedad o condicion mediada por el bloqueo del canal de sodio epitelial.
BR112013019181A2 (pt) c~ 11~ a c~ 13~ dialquil ésteres de ácido furandicarboxílico, plastificante, processo de preparação de um plastificante, usos dos plastificantes, polímeros, composição de polímero e moldagem ou filme
BR112015022566A2 (pt) composto e composição farmacêutica
UY33183A (es) Compuestos inhibidores de virus flaviviridae, composición farmaceutica que los contiene y su uso en la manufactura de un medicamento
BR112014012056A8 (pt) compostos farmacêuticos
CO6400151A2 (es) Policarbonatos hiperramificados para la solubilización de sustancias activas dificilmente solubles
BR112017005185A2 (pt) composições poliméricas
BR112013030391A2 (pt) derivados de piperidina 3- espirocíclicos como agonistas dos receptores de grelina
BR112012015184A2 (pt) "processo para preparar um éster cíclico, copolímero, micropartícula,e, micela de polímero"
BR112015028414A2 (pt) composição farmacêutica de micela de polímero
BR112015018504A2 (pt) moduladores de flap
UY31645A1 (es) Nuevas imidazolidinas fenil-sustituidas, procedimiento para su preparación, medicamentos que conprenden dichos compuestos y su uso.
ECSP14023048A (es) Agentes terapéuticos para administración subcutánea optimizados
BR112015028040A2 (pt) polímero contendo cadeia principal derivada de acrilato, métodos para preparar polímeros, formulações farmacêuticas e métodos para aumentar a solubilidade de um fármaco
BR112014032583A8 (pt) forma farmacêutica para liberação prolongada de substâncias ativas e seu processo de produção
BR112016002342A2 (pt) Microesfera entecavir, método para preparação de uma microesfera entecavir, e, composição farmacêutica
CL2018003682A1 (es) Composición farmacéutica oral, que comprende un agente farmacéuticamente activo, al menos un polímero catiónico bioadhesivo y al menos dos polímeros aniónicos.
EA201390979A1 (ru) Композиции бензимидазолов с модифицированным высвобождением
BR112013001462B8 (pt) Composições

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: DERMTREAT A/S (DK)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B25D Requested change of name of applicant approved

Owner name: AFYX THERAPEUTICS A/S (DK)

B25G Requested change of headquarter approved

Owner name: AFYX THERAPEUTICS A/S (DK)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements